COPE-ICD: A randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population

BMC Cardiovascular Disorders

Volumn 11, Issue , 2011, Pages

  Berg, Selina K ^a,b   Svendsen, Jesper H ^a   Zwisler, Ann Dorthe ^a,c   Pedersen, Birthe D ^c   Preisler, Pernille ^a   Siersbæk Hansen, Lone ^a   Hansen, Mette B ^a   Nielsen, Rune H ^a   Pedersen, Preben U ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; NITRATE;

ABSENTEEISM; ADULT; AGED; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; EXERCISE; FEMALE; HEALTH PROGRAM; HEART ARRHYTHMIA; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOEDUCATION; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; SEXUAL DYSFUNCTION; ADAPTIVE BEHAVIOR; ATTITUDE TO HEALTH; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DENMARK; EQUIPMENT; FEAR; HEALTH BEHAVIOR; INSTRUMENTATION; MENTAL STRESS; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; PSYCHOSEXUAL DISORDER; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DENMARK; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE; EXERCISE; FEAR; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; RESEARCH DESIGN; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958806315     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-11-33     Document Type: Article

References (50)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, . American College of Cardiology American Heart Association Task Force European Society of Cardiology Committee for Practice Guidelines European Heart Rhythm Association Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006, 8:746-837. American College of Cardiology American Heart Association Task Force European Society of Cardiology Committee for Practice Guidelines European Heart Rhythm Association Heart Rhythm Society.
2. Al-Khatib SM, Sanders GD, Carlson M, Cicic A, Curtis A, Fonarow GC, Groeneveld PW, Hayes D, Heidenreich P, Mark D, Peterson E, Prystowsky EN, Sager P, Salive ME, Thomas K, Yancy CW, Zareba W, Zipes D. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J 2008, 156:613-622. 10.1016/j.ahj.2008.05.027, 18926144.
3. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 2000, 101:1660-1664.
4. Thomas SA, Friedmann E, Kelley FJ. Living with an implantable cardioverter-defibrillator: a review of the current literature related to psychosocial factors. AACN Clin Issues 2001, 12:156-163. 10.1097/00044067-200102000-00015, 11288324.
5. Sears SF, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 1999, 22:481-489. 10.1002/clc.4960220709, 10410293.
6. Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung 2004, 33:176-182. 10.1016/j.hrtlng.2004.02.005, 15136777.
7. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005, 46:451-457. 10.1176/appi.psy.46.5.451, 16145190.
8. Godemann F, Butter C, Lampe F, Linden M, Werner S, Behrens S. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD). Qual Life Res 2004, 13:411-416.
9. Steinberg JS, Arshad A, Kowalski M, Kukar A, Suma V, Vloka M, Ehlert F, Herweg B, Donnelly J, Philip J, Reed G, Rozanski A. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack. J Am Coll Cardiol 2004, 44:1261-1264. 10.1016/j.jacc.2004.06.032, 15364329.
10. Shedd OL, Sears SF, Harvill JL, Arshad A, Conti JB, Steinberg JS, Curtis AB. The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City. J Am Coll Cardiol 2004, 44:1265-1267. 10.1016/j.jacc.2004.04.058, 15364330.
11. Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients' long-term adjustment to the ICD: a prospective study. Pacing Clin Electrophysiol 2000, 23:450-456. 10.1111/j.1540-8159.2000.tb00826.x, 10793433.
12. Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 2008, 65:1324-1330. 10.1001/archpsyc.65.11.1324, 18981344.
13. Davids JS, McPherson CA, Earley C, Batsford WP, Lampert R. Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey. Arch Phys Med Rehabil 2005, 86:1924-1928. 10.1016/j.apmr.2005.04.009, 16213232.
14. Dougherty CM, Glenny R, Kudenchuk PJ. Aerobic exercise improves fitness and heart rate variability after an implantable cardioverter defibrillator. J Cardiopulm Rehabil Prev 2008, 28:307-311. 2668254, 18784539.
15. Belardinelli R, Capestro F, Misiani A, Scipione P, Georgiou D. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev Rehabil 2006, 13:818-825. 10.1097/01.hjr.0000230104.93771.7d, 17001224.
16. Vanhees L, Kornaat M, Defoor J, Aufdemkampe G, Schepers D, Stevens A, Van Exel H, Van Den Beld J, Heidbuchel H, Fagard R. Effect of exercise training in patients with an implantable cardioverter defibrillator. Eur Heart J 2004, 25:1120-1126. 10.1016/j.ehj.2004.04.034, 15231370.
17. Vanhees L, Schepers D, Heidbuchel H, Defoor J, Fagard R. Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease. Am J Cardiol 2001, 87:712-715. 10.1016/S0002-9149(00)01488-0, 11249888.
18. Fan S, Lyon CE, Savage PD, Ozonoff A, Ades PA, Balady GJ. Outcomes and adverse events among patients with implantable cardiac defibrillators in cardiac rehabilitation: a case-controlled study. J Cardiopulm Rehabil Prev 2009, 29:40-43.
19. Crossmann A, Schulz SM, Kuhlkamp V, Ritter O, Neuser H, Schumacher B, Bauer W, Pauli P. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med 2010, 72:434-441. 10.1097/PSY.0b013e3181d9bcec, 20410252.
20. Dougherty CM, Lewis FM, Thompson EA, Baer JD, Kim W. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004, 27:1594-1602. 10.1111/j.1540-8159.2004.00691.x, 15613121.
21. Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, O'Brien MC, Weintraub WS. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 2009, 32:1259-1271. 10.1111/j.1540-8159.2009.02495.x, 2757745, 19796343.
22. Kuhl EA, Sears SF, Vazquez LD, Conti JB. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program. J Cardiovasc Nurs 2009, 24:225-231.
23. Lewin RJ, Coulton S, Frizelle DJ, Kaye G, Cox H. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart 2009, 95:63-69.
24. Dickerson SS, Wu YW, Kennedy MC. A CNS-facilitated ICD support group: a clinical project evaluation. Clin Nurse Spec 2006, 20:146-153. 10.1097/00002800-200605000-00013, 16705287.
25. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999, 9:163-168. 10.1002/(SICI)1520-6394(1999)9:4<163::AID-DA3>3.0.CO;2-B, 10431681.
26. Frizelle DJ, Lewin RJ, Kaye G, Hargreaves C, Hasney K, Beaumont N, Moniz-Cook E. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br J Health Psychol 2004, 9:381-392.
27. Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart 2003, 89:155-160. 10.1136/heart.89.2.155, 1767543, 12527665.
28. Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 2007, Thousand Oaks, Calif.: SAGE Publications.
29. Parse RR. The human becoming school of thought: a perspective for nurses and other health professionals. 1998, Thousand Oaks, Calif.: Sage.
30. Perk J, Mathes P, Gohlke H, Monpére C, Hellemans I, McGee H, Sellier P, Saner H, . eds Cardiovascular Prevention and Rehabilitation. 2007, London: Springer-Verlang, eds.
31. Tabet JY, Meurin P, Ben Driss A, Thabut G, Weber H, Renaud N, Odjinkem N, Solal AC. Determination of exercise training heart rate in patients on beta-blockers after myocardial infarction. Eur J Cardiovasc Prev Rehabil 2006, 13:538-543. 10.1097/01.hjr.0000209813.05573.4d, 16874142.
32. Lampman RM, Knight BP. Prescribing exercise training for patients with defibrillators. Am J Phys Med Rehabil 2000, 79:292-297. 10.1097/00002060-200005000-00012, 10821316.
33. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
34. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263. 10.1097/00005650-199303000-00006, 8450681.
35. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee to Update the 1997 Exercise Testing Guidelines. ACC/AHA 2002 guideline update for exercise testing: summary article. J Am Coll Cardiol 2002, 40:1531-1540. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines), 10.1016/S0735-1097(02)02164-2, 12392846.
36. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.
37. Wright DJ, Khan KM, Gossage EM, Saltissi S. Assessment of a low-intensity cardiac rehabilitation programme using the six-minute walk test. Clin Rehabil 2001, 15:119-124. 10.1191/026921501671364449, 11330756.
38. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 1985, 8:15-24.
39. Beery TA, Baas LS, Matthews H, Burroughs J, Henthorn R. Development of the implanted devices adjustment scale. Dimens Crit Care Nurs 2005, 24:242-248. 10.1097/00003465-200509000-00012, 16258358.
40. Steinke EE, Gill-Hopple K, Valdez D, Wooster M. Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung 2005, 34:299-308. 10.1016/j.hrtlng.2005.03.002, 16157184.
41. Polit DFHBP. Essentials of Nursing Research, Methods, Appraisal, and Utilization. 1997, Lippincott.
42. Ricoeur P. Time and narrative. 1988, The University of Chicago Press.
43. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000, 355:1064-1069. 10.1016/S0140-6736(00)02039-0, 10744093.
44. Kruse M, Hochstrasser S, Zwisler AD, Kjellberg J. Comprehensive cardiac rehabilitation: a cost assessment based on a randomized clinical trial. Int J Technol Assess Health Care 2006, 22:478-483.
45. World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects. JAMA 2000, 284:3043-3045. World Medical Association Declaration of Helsinki.
46. Gibbons L, Blair SN, Kohl HW, Cooper K. The safety of maximal exercise testing. Circulation 1989, 80:846-852.
47. Steinberg JS, Joshi S, Schron EB, Powell J, Hallstrom A, McBurnie M, . AVID Investigators Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm 2008, 5:361-365. 10.1016/j.hrthm.2007.11.010, 18313592, AVID Investigators.
48. Kao CW, Friedmann E, Thomas SA. Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Qual Life Res 2010, 19:307-315. 10.1007/s11136-010-9596-6, 20127419.
49. Kim JS, Pressler SJ, Welch JL, Damush T, Sloan RS, Wu J, Groh WJ. Physical function of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs 2009, 24:398-409.
50. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, . Multicenter InSync ICD II Study Group Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004, 110:2864-2868. 10.1161/01.CIR.0000146336.92331.D1, 15505095, Multicenter InSync ICD II Study Group.